Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation With Low Level Laser in the Prevention and Treatment of Oral Lesions (Mucositis, Hyposalivation and Osteonecrosis) Resulting From Anti-neoplastic Treatment With Chemotherapy or Radiotherapy.

NCT04717765 is registered in ClinicalTrials.gov with University of Santiago de Compostela as lead sponsor.

NCT NCT04717765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation With Low Level Laser in the Prevention and Treatment of Oral Lesions (Mucositis, Hyposalivation and Osteonecrosis) Resulting From Anti-neoplastic Treatment With Chemotherapy or Radiotherapy.
Lead sponsor
University of Santiago de Compostela
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2021
Completion date
August 31, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, hyposalivation, oral cancer, oral mucositis, osteonecroses, bisphosphonate, osteonecrosis due to drugs, jaw, osteoradionecrosis